These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7533682)

  • 1. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
    Munson LG; Scott ME; Landay AL; Spear GT
    Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
    Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
    Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).
    Solomon S; Kolb C; Mohanty S; Jeisy-Walder E; Preyer R; Schöllhorn V; Illges H
    Eur J Immunol; 2002 Mar; 32(3):644-51. PubMed ID: 11857338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
    J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
    Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
    Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
    Delibrias CC; Kazatchkine MD; Fischer E
    Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
    Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
    Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
    Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
    Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells.
    Thieblemont N; Haeffner-Cavaillon N; Haeffner A; Cholley B; Weiss L; Kazatchkine MD
    J Immunol; 1995 Nov; 155(10):4861-7. PubMed ID: 7594489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saarloos MN; Koenig RE; Spear GT
    J Infect Dis; 1995 Oct; 172(4):1095-7. PubMed ID: 7561187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptors regulate lipopolysaccharide-induced T-cell stimulation.
    Kaya Z; Tretter T; Schlichting J; Leuschner F; Afanasyeva M; Katus HA; Rose NR
    Immunology; 2005 Apr; 114(4):493-8. PubMed ID: 15804286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.